Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-01-09T03:40:52.219Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Carbamazepine in Psychosis after Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  03 January 2018

Malcolm Peet  and
John Collier
Malcolm Peet*
Affiliation:
Department of Psychiatry, Northern General Hospital, Sheffield S5 7AU
John Collier
Affiliation:
Department of Psychiatry, Northern General Hospital, Sheffield S5 7AU
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

A case is described of NMS during treatment with sulpiride. The subsequent psychosis resolved during treatment with carbamazepine. It is proposed that this patient may have suffered from a supersensitivity psychosis, and that resolution of her post-NMS psychosis could have been spontaneous.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 156 , Issue 4 , April 1990 , pp. 579 - 581
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Caine, E. D., Margolin, D. I., Brown, G. L. et al (1978) Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent. American Journal of Psychiatry, 135, 241–243.Google Scholar
Chouinard, G. & Jones, B. D. (1978) Neuroleptic-induced supersensitivity psychosis. American Journal of Psychiatry, 135, 1409–1410.Google ScholarPubMed
Cookson, J. C. (1987) Carbamazepine in acute mania: a practical review. International Clinical Psychopharmacology, 2 (suppl. 1), 11–22.Google Scholar
Davis, K. L. & Rosenberg, G. S. (1979) Is there a limbic system equivalent of tardive dyskinesia? Biological Psychiatry, 14, 699–703.Google Scholar
Klein, E., Bental, E., Lerer, B., et al (1984) Carbamazepine and haloperidol v placebo and haloperidol in excited psychosis. Archives of General Psychiatry, 41, 165–170.Google Scholar
Levenson, J. L. & Fisher, J. G. (1988) Long-term outcome after neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 49, 154–156.Google Scholar
Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799–812.CrossRefGoogle Scholar
Sale, I. & Kristall, H. (1978) Schizophrenia following withdrawal from chronic phenothiazine administration: a case report. Australian and New Zealand Journal of Psychiatry, 12, 73–75.Google Scholar
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica, 73, 337–347.Google Scholar
Simpson, G. M., Lee, J. H., Zorbok, B., et al (1979) A rating scale for tardive dyskinesia. Psychopharmacology, 64, 171–179.Google Scholar
Weinberger, D. R., Bigelow, L. B., Klein, S. T., et al (1981) Drug withdrawal in chronic schizophrenic patients: in search of neuroleptic-induced supersensitivity psychosis. Journal of Clinical Psychopharmacology, 1, 120–123.Google Scholar
Wells, A. J., Sommi, R. W. & Crismon, M. L. (1988) Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review. Drug Intelligence and Clinical Pharmacy, 22, 475–479.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.